Life Sciences and Pharmaceutical

Business Drivers and Trends:

Pharma Industry is undergoing major transformation with most patents nearing end term cycle. India being the largest manufacturers of vaccines and highest number of USFDA plants outside the USA is a global leaders in providing OTS generics.

India is attractive destination for OTC and emerging drugs, vaccines at low cost and global volumes and with Indian Market being thirteenth-largest in value and third largest in consumption.

Gene and next-generation therapy in areas as oncology, auto immunity etc. will continue to attract interest from large global Pharmaceutical companies.

Pharma industry is challenged by lack of IPs and new drug discovery resulting in divestiture of non-core assets, acquisition of high value chain companies in cell, gene, oncology and setting up of offshore R&D.

How Emaxiz can help Lifesciences and Pharma Companies?

With Global Investment Advisory, Amaxiz helps companies expand into emerging countries as India through Leverage buy-outs, JVs and partnerships in areas as biologic therapeutics in rare immune diseases, precision medicine, mRNA, genome sequencing etc.

Digital Advisory and Transformation Strategy helps pharmaceutical companies define their Digital Blueprint, IT budget and address business drivers as:

1. Leverage AI to predict the Individual healthcare and Enterprise data Strategy

2. Reduction of the product life cycle using AI and ML for new drug discovery, trials and offshore labs.